Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Show more...
CEO
Mr. Sanjay Prabhakar Murdeshwar
従業員
81
国
IN
ISIN
INE234A01025
上場銘柄
0 Comments
意見をシェア
FAQ
Novartis Indiaの株価は今日いくらですか?▼
NOVARTIND.NSE の現在価格は ₹674 INR で、過去24時間で -2.66% 下落しました。チャートで Novartis India 株価の動きを詳しく確認しましょう。